@Barkworth, the support at 0.5 is a very strong support and I look into the financial of the company and they look strong ... it might go down but it worth a shot to buy it between 0.5 and 0.8 because we can come back to 8 or 10 but the downside is limited as if we close below 0.5 you get out
@magnum375, Yes, I agree with that. Buy between 0.5 and 0.8, then hold you breath for a bounce. But the company's financials are not good at all. Less than one year cash runway, last quarter lost a lot of market share to peers. We have to be very careful with this asset.
@magnum375, I think this is the dip to buy. Sell off after the 12-1 split. Earnings is scary, I think their valuation is pretty good right now, though that doesn't mean there isn't downside, but the one thing that worries me, is the $2.4B goodwill for Medreleaf they have on that balance sheet. We could see a $1B write off there. Though in terms of assets, etc. they are pretty good value right now. We'll have to see them meet the revenue targets though, and improved EBITDA. Earnings on May 14th. I am on the fence. I may play. They could surprise. Though most peers missed.